PHACTR3-AS1: A Potential Drug Target and Biomarker (G100506384)

Target Name: PHACTR3-AS1

NCBI ID: G100506384

PHACTR3-AS1

Other Name(s): PHACTR3 antisense RNA 1

PHACTR3-AS1: A Potential Drug Target and Biomarker

PHACTR3-AS1 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its full name is PHACTR3-AS1-containing gene 3, and it is a member of the PHACTR gene family. PHACTR3-AS1 has been shown to play a role in the regulation of cellular processes, including cell adhesion, migration, and survival.

Recent studies have identified PHACTR3-AS1 as a potential drug target due to its involvement in various cellular processes that are associated with diseases such as cancer, neurodegenerative diseases, and autoimmune disorders. Additionally, its expression has been shown to be regulated by various signaling pathways, including TGF-β, NF-kappa-B, and PI3K/AKT signaling pathways.

As a potential drug target, PHACTR3-AS1 can be targeted by small molecules or antibodies that can modulate its activity. For example, inhibition of PHACTR3-AS1 has been shown to reduce the migration and invasion of cancer cells, and to protect against neurodegenerative diseases. Additionally, antibodies against PHACTR3-AS1 have been shown to protect against DNA damage and to regulate cellular processes that are associated with aging and neurodegenerative diseases.

As a biomarker, PHACTR3-AS1 can be used to diagnose and monitor various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, its expression has been shown to be elevated in various tissues of cancer, and its levels have been used as a biomarker to predict the prognosis in patients with breast cancer. Additionally, PHACTR3-AS1 has been shown to be involved in the regulation of cellular processes that are associated with aging, such as DNA damage and neurodegeneration, and its levels have been used as a biomarker to predict the risk of age-related diseases.

In conclusion, PHACTR3-AS1 is a protein that has been shown to play a role in various cellular processes that are associated with diseases such as cancer, neurodegenerative diseases, and autoimmune disorders. Its potential as a drug target and biomarker makes it an attractive target for further research and development.

Protein Name: PHACTR3 Antisense RNA 1

The "PHACTR3-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PHACTR3-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets